Evidence map›Paper›PMID 30442930›Full record

ArticleScientific reports2018

A 5'-BODIPY End-label for Monitoring DNA Duplex-Quadruplex Exchange.

Prashant S Deore, Dmitriy V Soldatov, Richard A Manderville

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. BODIPY-fused uracil: synthesis, photophysical properties, and applications.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Article
  3. Article
  4. Green-Light Activatable BODIPY and Coumarin 5'-Caps for Oligonucleotide Photocaging.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Prashant S DeoreDepartments of Chemistry and Toxicology, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.
Dmitriy V SoldatovDepartments of Chemistry and Toxicology, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.ORCID http://orcid.org/0000-0002-2101-8010
Richard A MandervilleDepartments of Chemistry and Toxicology, University of Guelph, Guelph, Ontario, N1G 2W1, Canada. rmanderv@uoguelph.ca.
University of Guelph · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescent probes that can distinguish different DNA topologies through changes in optical readout are sought after for DNA-based diagnostics. In this work, the 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene (BODIPY) chromophore attached to cyanophenyl substituents (BODIPY-CN) has been tethered to the 5'-end of the 15-mer thrombin binding aptamer (TBA) that contains the guanine (G) nucleobase. TBA folds into a unimolecular antiparallel G-quadruplex (GQ) upon binding thrombin and certain metal ions. The 5'-BODIPY-CN-TBA sample possesses a Stokes shift of ~40 nm with wavelengths of excitation/emission at 550/590 nm and exhibits a 2-fold increase in emission intensity compared to the free BODIPY-CN in aqueous buffer that possesses a brightness (εΦ

Indexed as

G-QuadruplexesStaining and LabelingBoron CompoundsKineticsMolecular ConformationSpectrometry, FluorescenceThrombinUltraviolet Rays4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsThrombin

Identifiers

PMID30442930
PMCPMC6237993
OpenAlexW2899777098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.